Article Excerpt: Many of the apps that pharma companies are developing to support conditions or specific drugs and diagnostics are either only available outside the U.S. or are still being evaluated in pilot studies. A specialist drug developer rolled out an app in December to support its drug to treat people for opioid abuse. The idea is for treatment centers and physicians to dispense the app to patients.
Full Article: http://tinyurl.com/ky7usow
Article Source: MedCity News